Public leery of third-party partnerships

Share this article:
A survey of public attitudes toward drug company partnerships with nonprofits has found skepticism of industry motives.

Among respondents to the Envision Solutions survey, 43% said pharmas fund groups like the American Heart Association and the National Kidney Foundation primarily to boost sales of their medicines.

The survey suggests a hardening of attitudes toward such partnerships. By contrast, only 10% of respondents to a similar question in a PRWeek/Barkley Public Relations poll last year said pharmas partner with non-profits primarily to boost profits.

Envision Solutions pointed to media coverage of “disease mongering” as a likely factor driving cynicism. The consultancy said the number of reports on that topic increased 775% from 2005 to 2006.

The online survey of 1,062 US adults was conducted by polling firm Kelton Research from April 10-13.

Share this article:

Email Newsletters

More in News

Astellas, DOJ settle for $7.3M

Astellas, DOJ settle for $7.3M

Astellas has settled a False Claims case with the Department of Justice over the 2010-2013 marketing of an antifungal medication. Astellas denies the allegations.

Boehringer drug lands US, EU orphan tag

Boehringer drug lands US, EU orphan tag

The experimental Breakthrough Therapy treatment is for acute myeloid leukemia.

Omnio app moves to smartphones

Omnio app moves to smartphones

Physicians Interactive is introducing the third wave of its Omnio app, making the tablet-only tool available for iPhones and Android phones.